|
New Chapter Zyflamend 
Studies:
1-Zyflamend, a unique herbal preparation with
nonselective COX inhibitory activity, induces apoptosis of prostate
cancer cells that lack COX-2 expression.1: Nutr
Cancer. 2005;52(2):202-12
PubMed
Ref #: 16201851
2-Inhibition of lipoxygenase activity: implications
for the treatment and chemoprevention of prostate cancer.1: Cancer
Biol Ther. 2007 Feb;6(2):237. Epub 2007 Feb 8.
PubMed:
17387265
3-The role of Zyflamend, an herbal
anti-inflammatory, as a potential chemopreventive agent against
prostate cancer: a case report.Integr
Cancer Ther. 2007 Mar;6(1):74-6
PMID: 17351029 [PubMed - indexed for MEDLINE]
4-Zyflamend-mediated inhibition of human prostate
cancer PC3 cell proliferation: effects on 12-LOX and Rb protein
phosphorylation Cancer
Biol Ther. 2007 Feb;6(2):228-36. Epub 2007 Feb 25
PMID: 17218785 [PubMed - indexed for MEDLINE]
Swanson Condition Specific Formulas Prostate Essentials Plus 
* These statements have not been evaluated by the
FDA. These products are not intended to diagnose, treat, cure, or
prevent any disease. If you are pregnant or planning on getting
pregnant in the near future always consult your primary care
provider before starting any new supplements.
* These statements have not been evaluated by the FDA. These
products are not intended to diagnose, treat, cure, or prevent any disease.
Contact your primary care provider prior to adding, changing, or
stopping any medications you may be taking, or adding any
supplements to the medications you take. A thorough discussion with
your primary care physician is imperative prior to any changes in
medications or supplements.
|
